Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dimebutic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimebutic Acid SCHEMBL1055425 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL1964556 | 0.94 | — | — | |
| Dimebutic Acid SCHEMBL28444778 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL28581861 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL15022227 | 0.94 | — | — | |
| Dimebutic Acid SCHEMBL13517329 | 0.94 | — | — | |
| Dimebutic Acid SCHEMBL1962002 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL8748037 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL8383022 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL8383026 | 0.94 | FFAR3 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118119386-A | Functionalized carboxylic acids and their use for treating diseases | 埃斯佩尔维塔治疗股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-114126593-A | Functionalized long chain hydrocarbon mono-and dicarboxylic acids useful for preventing or treating disease | 埃斯佩尔维塔治疗股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-7777071-B2 | Production of carnitine conjugate intermediates | SSV THERAPEUTICS, INC. (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090012160-A1 | Carnitine Conjugates As Dual Prodrugs, Methods Of Production And Uses Thereof | SSV THERAPEUTICS, INC. | 2009-01-08 | — | — | US | disclosed |
| WO-2008018877-A1 | CARNITINE CONJUGATES AS DUAL PRODRUGS, METHODS OF PRODUCTION AND USES THEREOF | SSV THERAPEUTICS, INC. (US) | 2008-02-14 | — | — | WO | disclosed |
| EP-0944654-B1 | ANIONIC POLYMERISATION OF ACRYLATES AND METHACRYLATES | BASF AG (DE) | 2002-03-20 | — | — | EP | disclosed |
| US-6262213-B1 | ANIONIC POLYMERIZATION OF ACRYLATS OR METHACRYLATES IN PRESENCE OF SOLVENT COMPRISING OLEFINICALLY UNSATURATED COMPOUND TO SUPPRESS GEL FORMATION OF REACTION MIXTURE | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | disclosed |
| EP-0944656-B1 | PROCESS FOR PREPARING RUBBER-MODIFIED MOULDING COMPOUNDS | BASF AG (DE) | 2001-07-11 | — | — | EP | disclosed |
| US-6211297-B1 | ANIONIC POLYMERIZATION; MOLDING MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-03 | — | — | US | disclosed |